Clinical trials
Phase 3 Acute Coronary Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 11 |
| 2011 | 9 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 76 |
| Unknown status | 14 |
| Terminated | 10 |
| Recruiting | 8 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| The Medicines Company | 5 |
| Eli Lilly and Company | 4 |
| GlaxoSmithKline | 4 |
| Sanofi | 4 |
| Assistance Publique Hopitaux De Marseille | 3 |
| Dong-A University | 3 |
| Novartis Pharmaceuticals | 3 |
| Organon and Co | 3 |
| Collegium Medicum w Bydgoszczy | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 115 |
| Myocardial Infarction | 29 |
| Coronary Artery Disease | 21 |
| Angina, Unstable | 19 |
| ST Elevation Myocardial Infarction | 17 |
| Non-ST Elevated Myocardial Infarction | 12 |
| Cardiovascular Diseases | 9 |
| Myocardial Ischemia | 8 |
| Atherosclerosis | 6 |
| Heart Diseases | 6 |
Trials
Showing 51 to 75 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.